ADULTS
Beyond's analysis on ADULTS
Recent news mentioning ADULTS
- — Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia
- — New Johnson & Johnson ICOTYDE® (icotrokinra) long-term data demonstrate robust 2-year results in the treatment of adults and adolescents with plaque psoriasis
- — New Phase 3b data on Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) advance understanding of the interconnected immune and metabolic biology in adults with psoriasis and obesity
- — Viola Davis partners with GSK to educate adults 50 and older about their shingles risk
- — Most adults brush and floss daily, yet only 55% replace their toothbrush as recommended
- — Let's Turn Halloween into an Awareness Event for Adults Who Answer the Door
- — In HelloNation, Dental Expert Dustin Plunkett Reviews Clear Aligner Options for Adults
- — Daily Walnut Consumption May Improve Mood in Young Adults
- — American Lung Association Encourages Older Adults to Talk to Their Healthcare Provider About RSV Vaccination
- — More than 10 million older adults are now living in poverty as Social Security cuts loom: ‘I don’t know how anyone is making it’
- — What Are the 5 Signs of Poor Metabolic Health Adults May Overlook?
- — Novo’s Wegovy® (semaglutide) reduced liver fat to normal levels in 9 out of 10 adults with obesity and excess liver fat – EASD2026